The Non-alcoholic Steatohepatitis (NASH) Market addresses the therapeutic and diagnostic needs for the progressive form of Non-alcoholic Fatty Liver Disease (NAFLD), recently renamed Metabolic dysfunction-associated Steatohepatitis (MASH). NASH/MASH is a serious chronic liver disease characterized by fat accumulation, inflammation, and liver cell damage, often leading to fibrosis, cir... https://www.databridgemarketresearch.com/